Cargando…

First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001‐2012

The aim of this study was to assess the outcome of patients with aplastic anemia (AA), receiving rabbit anti‐thymocyte globulin (Thymoglobulin, SANOFI) and cyclosporin, as first line treatment. Eligible were 955 patients with AA, treated first line with Thymoglobulin, between 2001 and 2008 (n = 492)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacigalupo, Andrea, Oneto, Rosi, Schrezenmeier, Hubert, Hochsmann, Britta, Dufour, Carlo, Kojima, Seiji, Zhu, Xiaofan, Chen, Xiaojuan, Issaragrisil, Surapol, Chuncharunee, Suporn, Jeong, Dae Chul, Giammarco, Sabrina, Van Lint, Maria Teresa, Zheng, Yizhou, Vallejo, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667908/ https://www.ncbi.nlm.nih.gov/pubmed/29498107 http://dx.doi.org/10.1002/ajh.25081

Ejemplares similares

Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study
por: Norasetthada, Lalita, et al.
Publicado: (2021)

Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
por: Kunacheewa, Chutima, et al.
Publicado: (2020)

Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy
por: Bacigalupo, Andrea, et al.
Publicado: (2019)

Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation
por: Tichelli, André, et al.
Publicado: (2020)

An avoidable cause of thymoglobulin anaphylaxis
por: Brabant, S., et al.
Publicado: (2017)

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)—report on phases I and II
por: Groth, Martha, et al.
Publicado: (2016)

Thymoglobulin – new approaches to optimal outcomes
por: Delia Moiceanu, Andreea, et al.
Publicado: (2009)

Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)—a report on phase III
por: Niedeggen, Cathrin, et al.
Publicado: (2019)

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
por: Höchsmann, Britta, et al.
Publicado: (2011)

955. Addressing Gaps and Disparities in HIV testing in the Emergency Department
por: Huggett, Ashley, et al.
Publicado: (2020)

Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015)

Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
por: Saeed, Muhammad I., et al.
Publicado: (2020)

Grafalon® vs. Thymoglobulin® as an Induction Agent in Renal Transplantation – A Retrospective Study
por: Jha, Pranaw Kumar, et al.
Publicado: (2021)

Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
por: Bacigalupo, Andrea
Publicado: (2023)

Bone marrow non-mesenchymal mononuclear cells induce functional differentiation of neuroblastoma cells
por: Phruksaniyom, Chareerut, et al.
Publicado: (2013)

Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
por: Angsutararux, Paweorn, et al.
Publicado: (2015)

Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies
por: Pratumkaew, Ponthip, et al.
Publicado: (2021)

Role of YAP as a Mechanosensing Molecule in Stem Cells and Stem Cell-Derived Hematopoietic Cells
por: Damkham, Nattaya, et al.
Publicado: (2022)

LB955 Adherence in dermatology during the COVID-19 pandemic: A review
por: Bridgeman, S.G., et al.
Publicado: (2022)

O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination
por: Samart, Parinya, et al.
Publicado: (2021)

Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
por: Luanpitpong, Sudjit, et al.
Publicado: (2021)

A novel E-cadherin/SOX9 axis regulates cancer stem cells in multiple myeloma by activating Akt and MAPK pathways
por: Samart, Parinya, et al.
Publicado: (2022)

Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells
por: Klaihmon, Phatchanat, et al.
Publicado: (2023)

Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
por: Klaihmon, Phatchanat, et al.
Publicado: (2023)

A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition
por: Barten, Markus J., et al.
Publicado: (2016)

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT
por: Toor, A, et al.
Publicado: (2008)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand
por: Chuncharunee, Suporn, et al.
Publicado: (2019)

Draft Genome Sequence of Rifamycin Derivatives Producing Amycolatopsis mediterranei Strain DSM 46096/S955
por: Singh, Priya, et al.
Publicado: (2014)

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL-LIFE EXPERIENCE OF EMMY
por: Hulin, C., et al.
Publicado: (2022)

Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review
por: Sandhu, Amarpreet, et al.
Publicado: (2012)

Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?
por: Hardinger, Karen L., et al.
Publicado: (2010)

A Statistical Report on 955 Cases of Cancer of the Cervix Uteri and 321 Cases of Cancer of the Corpus Uteri
por: Harnett, W. L.
Publicado: (1949)

Statement on the validity of the conclusions of a mouse carcinogenicity study on sucralose (E 955) performed by the Ramazzini Institute
por: Aguilar, Fernando, et al.
Publicado: (2017)

955. Trends in Top COVID-19 Questions Among a National Audience of Primary Care Clinicians
por: Madore, Aylin, et al.
Publicado: (2021)

P955: BURDEN OF INFECTION IN PATIENTS WITH MULTIPLE MYELOMA AND SECONDARY IMMUNODEFICIENCIES: A RETROSPECTIVE COHORT STUDY
por: Richter, Joshua, et al.
Publicado: (2023)

Comparative Efficacy and Clinical Outcomes of Haploidentical Stem Cell Transplantation to Other Stem Sources for Treatment in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis
por: Kunacheewa, Chutima, et al.
Publicado: (2020)

Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions
por: Klaihmon, Phatchanat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7qmdq9cbc3vcpphbk2cr55pi0n